1 |
Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34, 482-492
DOI
ScienceOn
|
2 |
Lim, J.A., A.R. Kwon, S.K. Kim, Y. Chong, K. Lee, and E.C. Choi. 2002. Prevalence of resistance to macrolide, lincosamide and streptogramin antibiotics in Gram-positive cocci isolated in a Korean hospital. J. Antimicrob. Chemother. 49, 489-495
DOI
ScienceOn
|
3 |
Levin, T.P., B. Suh, P. Axelrod, A.L. Truant, and T. Fekete. 2005. Potential clindamycin resistance in clindamycin-susceptible, erythromycin- resistant Staphylococcus aureus: Report of a clinical failure. Antimicrob. Agents Chemother. 49, 1222-1224
DOI
ScienceOn
|
4 |
Martineau, F., F.J. Picard, N. Lansac, C. Menard, P.H. Roy, M. Ouellette, and M.G. Bergeron. 2000. Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotic susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 44, 231-238
DOI
|
5 |
National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility tests. Supplement M100-S12. National Committee for Clinical Laboratory Standards, Wayne, Pa, USA
|
6 |
Allignet, J., V. Loncle, and N. Solh. 1992. Sequence of a staphylococcal plasmid gene, vga, encoding a putative ATP-binding protein involved in resistance to virginianmycin A-like antibiotics. Gene. 117, 45-55
DOI
ScienceOn
|
7 |
Thakker-Varia, S., W.D. Jenssen, L. Moon-McDermott, M.P. Weinstein, and D.T. Dubin. 1987. Molecular epidemiology of macrolidelincosamide- streptogramin B resistance in Staphylococcus aureus and coagulase-negative staplylococci. Antimicrob. Agents Chemother. 31, 735-743
DOI
PUBMED
ScienceOn
|
8 |
Weisblum, B. 1995. Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother. 39, 577-585
DOI
PUBMED
ScienceOn
|
9 |
Drinkovic, D., E.R. Fuller, K.P. Shore, D.J. Holland, and R. Ellis- Pegler. 2001. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J. Antimicrob. Chemother. 48, 315-316
DOI
ScienceOn
|
10 |
Schmitz, F.J., R. Sadurski, A. Kray, M. Boos, R. Geisel, K. Kohrer, J. Verhoef, and Ad C. Fluit. 2000. Prevalence of macrolideresistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J. Antimicrob. Chemother. 45, 891-894
DOI
ScienceOn
|
11 |
Westh, H., D.M. Hougaard, J. Vuust, and V.T. Rosdahl. 1995. Prevalence of erm gene classes in erythromycin-resistant Staphylococcus aureus strains isolated between 1959 and 1988. Antimicrob. Agents Chemother. 39, 369-373
DOI
PUBMED
ScienceOn
|
12 |
Watanakunakorn, C. 1976. Clindamycin therapy of Staphylococcus aureus endocarditis: clinical relapse and development of resistance to clindamycin, lincomycin and erythromycin. Am. J. Med. 60, 419-425
DOI
ScienceOn
|
13 |
Ozyurt, M., B. Sareyyupoglu, and N. Ardıc. 2004. Erythromycin and tetracycline resistance genes were investigated in methicilline resistant staphylococci isolates by multiplex-PCR. XXX1. TMC Congress Abstr. 262
|
14 |
Fiebelkorn, K.R., S.A. Crawford, M.L. McElmeel, and J.H. Jorgensen. 2003. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and Coagulase- negative Staphylococci. J. Clin. Microbiol. 41, 4740-4744
DOI
|